Katie Quinn

2.6k total citations
37 papers, 664 citations indexed

About

Katie Quinn is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katie Quinn has authored 37 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 17 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katie Quinn's work include Cancer Genomics and Diagnostics (23 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Katie Quinn is often cited by papers focused on Cancer Genomics and Diagnostics (23 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Katie Quinn collaborates with scholars based in United States, Canada and United Kingdom. Katie Quinn's co-authors include M C Allison, Ilona Shilliday, Narendra Maheshri, Nigam H. Shah, Frank Cuttitta, Alfredo Martı́nez, Mark Miller, Edward J. Unsworth, Masahito Ebina and Kimberly C. Banks and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Katie Quinn

29 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katie Quinn United States 10 186 185 183 178 119 37 664
Jackie McDonald United States 10 273 1.5× 117 0.6× 169 0.9× 98 0.6× 185 1.6× 15 783
Zhijian Li China 16 382 2.1× 107 0.6× 74 0.4× 97 0.5× 372 3.1× 44 881
Clemens Grupp Germany 15 258 1.4× 199 1.1× 135 0.7× 31 0.2× 142 1.2× 49 857
Hyun Hee Lee South Korea 15 243 1.3× 38 0.2× 72 0.4× 106 0.6× 165 1.4× 43 603
Yıldız Okuturlar Türkiye 13 103 0.6× 149 0.8× 70 0.4× 72 0.4× 48 0.4× 55 475
Tiffanie K. Jones United States 11 117 0.6× 70 0.4× 153 0.8× 64 0.4× 36 0.3× 18 666
Bili Zhang China 11 128 0.7× 59 0.3× 64 0.3× 56 0.3× 47 0.4× 45 486
Panpan Wang China 9 117 0.6× 46 0.2× 60 0.3× 71 0.4× 69 0.6× 19 663
Jianhua Li China 13 173 0.9× 120 0.6× 85 0.5× 108 0.6× 11 0.1× 54 561

Countries citing papers authored by Katie Quinn

Since Specialization
Citations

This map shows the geographic impact of Katie Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Quinn more than expected).

Fields of papers citing papers by Katie Quinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Quinn. The network helps show where Katie Quinn may publish in the future.

Co-authorship network of co-authors of Katie Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Quinn. A scholar is included among the top collaborators of Katie Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Quinn. Katie Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Quandt, Zoe, Sean Gordon, Kyle Chang, et al.. (2025). Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study. Cancer Research Communications. 5(8). 1384–1395.
3.
Loree, Jonathan M., Emma Titmuss, James T. Topham, et al.. (2024). Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical Cancer Research. 30(15). 3189–3199. 11 indexed citations
4.
Raghav, Kanwal, Lianchun Xiao, Courtney Lewis, et al.. (2024). A randomized study evaluating tailoring of advanced/metastatic colorectal cancer (mCRC) therapy using circulating tumor DNA (ctDNA): TACT-D.. Journal of Clinical Oncology. 42(17_suppl). LBA3557–LBA3557.
5.
Quinn, Katie, et al.. (2024). Fundamentals of DNA methylation in development. Pediatric Research. 98(2). 458–469.
6.
Yen, Jennifer, et al.. (2023). Abstract 3135: Validation of a bioinformatic model for classifying non-tumor variants in a cell-free DNA liquid biopsy assay. Cancer Research. 83(7_Supplement). 3135–3135. 1 indexed citations
7.
Quinn, Katie, Bethan E. Phillips, Daniel J. Wilkinson, et al.. (2023). Addition of very low calorie diet (VLCD) during initiation of semaglutide in individuals with type 2 diabetes – interim results. Clinical Medicine. 23(6). 71–71. 1 indexed citations
8.
Chen, Sai, Katie Quinn, Che-Yu Lee, et al.. (2023). Abstract 3123: A method for quantifying circulating tumor DNA level and molecular response using methylome sequencing. Cancer Research. 83(7_Supplement). 3123–3123. 4 indexed citations
9.
Lee, Jii Bum, Hyung Soon Park, Su Jin Choi, et al.. (2022). Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. Therapeutic Advances in Medical Oncology. 14. 4287553793–4287553793. 3 indexed citations
10.
Topham, James T., Chris J. O’Callaghan, Harriet Feilotter, et al.. (2022). Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer. Journal of Clinical Oncology. 41(3). 485–496. 38 indexed citations
11.
Thompson, Jeffrey C., Erica L. Carpenter, Austin L. Chien, et al.. (2021). Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy. JCO Precision Oncology. 5(5). 510–524. 62 indexed citations
12.
Si, Han, Michael Kuziora, Katie Quinn, et al.. (2020). A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study. Clinical Cancer Research. 27(6). 1631–1640. 86 indexed citations
13.
Aggarwal, Charu, Jeffrey C. Thompson, Austin L. Chien, et al.. (2019). MA25.04 Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Outcomes After Pembrolizumab Based First Line Therapy in Metastatic NSCLC. Journal of Thoracic Oncology. 14(10). S352–S352. 4 indexed citations
14.
Roisman, Laila C., Martina I. Lefterova, Katie Quinn, et al.. (2019). P1.04-47 Tumor Mutation Burden Through Hybrid Capture – Circulating Tumor DNA May Predict Response to Immunotherapy in NSCLC. Journal of Thoracic Oncology. 14(10). S459–S459.
15.
16.
Quinn, Katie & Nigam H. Shah. (2017). A dataset quantifying polypharmacy in the United States. Scientific Data. 4(1). 170167–170167. 55 indexed citations
17.
Maheshri, Narendra, et al.. (2013). Cell-Cycle Dependence of Transcription Dominates Noise in Gene Expression. DSpace@MIT (Massachusetts Institute of Technology). 115 indexed citations
18.
Shilliday, Ilona, Katie Quinn, & M C Allison. (1997). Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrology Dialysis Transplantation. 12(12). 2592–2596. 137 indexed citations
19.
Martı́nez, Alfredo, Mark Miller, Katie Quinn, et al.. (1995). Non-radioactive localization of nucleic acids by direct in situ PCR and in situ RT-PCR in paraffin-embedded sections.. Journal of Histochemistry & Cytochemistry. 43(8). 739–747. 65 indexed citations
20.
Quinn, Katie, et al.. (1992). A population-wide profile of prescription drug use in Saskatchewan, 1989.. PubMed. 146(12). 2177–86. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jackie McDonald Breakdown of academic impact, for papers by Zhijian Li Breakdown of academic impact, for papers by Clemens Grupp Breakdown of academic impact, for papers by Hyun Hee Lee Breakdown of academic impact, for papers by Yıldız Okuturlar Breakdown of academic impact, for papers by Tiffanie K. Jones Breakdown of academic impact, for papers by Bili Zhang Breakdown of academic impact, for papers by Panpan Wang Breakdown of academic impact, for papers by Jianhua Li
Rankless by CCL
2026